News & Events

  • Dr. John Frohna Named ACGME’s 2009 Parker J. Palmer Courage to Teach Award Recipient

    Posted: October 2009

    Congratulations to John Frohna, MD, MPH, recently named one of the ACGME’s (Accreditation Council for Graduate Medical Education) 2009 Parker J. Palmer Courage to Teach Award recipients. The Parker J. Palmer award honors up to 10 residency program directors each year for their dedication to teaching new physicians. We also have the rare distinction of having two program directors at our institution win the award as Dave Allen was a past recipient.

     
  • Jeffrey Sleeth, MD, Awarded UW Health Program Grant

    Posted: October 2009

    Congratulations to Jeff Sleeth, MD, a recent recipient of a UW Health Ambulatory Care Innovation Program Grant for his project, “Implementation of Development Screening Tools in Primary Care Clinics.”

     
  • Bruce Klein, MD, Awarded National Institutes of Health Funding

    Bruce Klein, MD, was recently awarded $995,500 over 2 years from the National Institutes of Health-National Institute of Allergy and Infectious Diseases for his project, “Targeting hybrid histidine kinase for broad spectrum antifungal therapy.” This project was funded under the American Recovery and Reinvestment Act (ARRA) of 2009 and will support a project to address the public health need for the development of effective new anti-fungal drugs by seeking to identify, characterize and capitalize on a novel drug target in pathogenic fungi.

    Dr. Bruce Klein, MD, also received an award of $297,000 over 2 years from the National Institutes of Health-National Institute of Allergy and Infectious Diseases as a supplement to his current project, “Mechanisms of Anti-fungal Vaccine Immunity.” These funds will support increased animal costs and allow for Dr. Klein’s continued progress on the research.

     
  • Judith Smith, MD, PhD, Receives Career Development Award

    Judith Smith, MD, PhD, recently received a career development award of $419,487 over 3 years from the National Institutes of Health-National Institute of Allergy and Infectious Diseases for her project, “Regulation of IFN-beta induction by P2X7 purinergic receptor signaling.” This project will study how substances that are released by tissue damage regulate the production of the inflammatory cytokine IFB-beta by macrophages. Greater understanding of inflammatory processes may ultimately lead to the better treatment of disease.

     
  • Megan Moreno, MD, MSEd, MPH, Awarded National Institutes of Health Funding

    Megan Moreno, MD, MSEd, MPH, recently received an award of $74,250 over 2 years from the National Institutes of Health-National Institute on Alcohol Abuse and Alcoholism for her project, “Facebook: A screening tool to identify alcohol use among female college freshmen.” This study will pilot test the use of a social networking Web site to identify female college freshmen who display references to alcohol use on their Facebook web profiles.

     
  • Dr. James Gern Awarded Baylor College of Medicine & National Institutes of Health Funding

    James Gern, MD, was recently awarded $25,964 from Baylor College of Medicine & National Institutes of Health for the project, “Development of a method for preparation of LPS-free rhinoviral proteases,” in conjunction with his U19 grant. This award will be used to produce LPS-free recombinant rhinovirus proteinases in Dr. Gern’s laboratory which will then be tested for proteinase activity and reactivity in an experimental model of asthma.

     
  • James Gern, MD, Awarded National Institutes of Health Funding

    James Gern, MD, was recently awarded $408,456 over 2 years from the National Institutes of Health-National Institute of Allergy and Infectious Diseases as a supplement to his current award, “Mechanisms of Rhinovirus-Induced Exacerbations of Asthma.” This project was funded under the American Recovery and Reinvestment Act (ARRA) of 2009 and will support a clinical trial to determine the best dose of a new human Rhinovirus type 16 inoculum manufactured using reverse genetics (RG-HRV16) for use in future experimental cold studies and to characterize the newly identified Rhinovirus type C and establish a tissue culture system to support RVC growth.

     
  • Megan Moreno, MD, MSEd, MPH Awarded National Institutes of Health Funding

    Posted: August 2009

    Megan Moreno, MD, MSEd, MPH, was recently awarded $312,600 over 2 years from the National Institutes of Health – National Institute on Alcohol Abuse and Alcoholism for her project, “Use of Social Networking Web sites for Problem Drinking Screening in Adolescents.” This study will pilot test the use of a social networking Web site to recruit adolescents for problem alcohol use screening. These Web sites are extremely popular among this age group and may be an untapped resource for identifying behaviors as well as providing communication and health information.

     
  • Dr. Robert Lemanske Awarded National Institutes of Health Funding

    Posted: August 2009

    Robert Lemanske, MD and Xin Sun, PhD, from the Department of Genetics, received funding of $350,000/year for 5 years from the National Institutes of Health for their project, “Investigating Effects of Viral Infection of Lung Development.” This project will use animal and human models to investigate interactive effects of respiratory virus infections and host genetic factors on the developing lung, with the goal of increasing our ability to predict, prevent and treat recurrent wheezing and childhood asthma.

     
  • David Delgado, MD, Awarded MACC Funding

    Posted: August 2009

    David Delgado, MD, received $30,000 from the Midwest Athletes Against Childhood Cancer for his project, “KIR-incompatible stem cell transplantation for pediatric osteosarcoma and other pediatric solid tumors: A preclinical model.” This pre-clinical study could provide the necessary information to allow KIR-incompatible stem cell transplantation as a viable treatment option for children with metastatic, recurrent or refractory solid tumors that have been unsuccessful with previous treatment strategies.